Intellipharmaceutics International Inc. (IPCIF)

IPCIF Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	0.08	0.08	0.77	0.2	6.64
Cash & Cash Equivalents	0.08	0.08	0.77	0.2	6.64
Cash Growth	0%	-89.15%	282.06%	-96.96%	250.11%
Receivables	0.39	0.39	0.27	1.05	1.24
Inventory	0	0	0.11	0.11	0.25
Other Current Assets	0.02	0.02	-0.05	0.12	0.59
Total Current Assets	0.49	0.49	1.1	1.48	8.72
Property, Plant & Equipment	0.94	0.94	0.99	1.91	2.76
Intangible Assets	0	0	0	0.01	0
Other Long-Term Assets	-0	-0	-0	-0.01	0
Total Long-Term Assets	0.94	0.94	0.99	1.91	2.76
Total Assets	1.43	1.43	2.1	3.39	11.47
Accounts Payable	3.76	3.76	3.78	4.1	2.64
Deferred Revenue	0	0	0	0	0.3
Current Debt	2.33	2.33	1.92	2.11	1.79
Other Current Liabilities	5.92	5.92	4.55	3.48	0.58
Total Current Liabilities	12.01	12.01	10.25	9.7	5.31
Other Long-Term Liabilities	0	0	0	0	2.06
Total Long-Term Liabilities	0	0	0	0	2.06
Total Liabilities	12.01	12.01	10.25	9.7	7.37
Total Debt	2.33	2.33	1.92	2.11	1.79
Debt Growth	-	21.31%	-9.24%	18.00%	38.74%
Common Stock	49.18	49.18	49.18	46.14	44.33
Retained Earnings	-105.13	-105.13	-102.24	-97.1	-85.62
Comprehensive Income	0.28	0.28	0.28	0.28	0.28
Shareholders' Equity	-10.58	-10.58	-8.16	-6.31	4.1
Total Liabilities and Equity	1.43	1.43	2.1	3.39	11.47
Net Cash / Debt	-2.24	-2.24	-1.15	-1.91	4.85
Net Cash / Debt Growth	-	-	-	-	699.79%
Net Cash Per Share	-0.07	-0.08	-0.05	-0.09	1.02
Working Capital	-11.52	-11.52	-9.15	-8.22	3.41
Book Value Per Share	-0.32	-0.36	-0.35	-0.29	0.86

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.